Correlation Between IShares Nasdaq and IShares MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Nasdaq and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Nasdaq and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Nasdaq Biotechnology and iShares MSCI Korea, you can compare the effects of market volatilities on IShares Nasdaq and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Nasdaq with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Nasdaq and IShares MSCI.

Diversification Opportunities for IShares Nasdaq and IShares MSCI

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between IShares and IShares is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding iShares Nasdaq Biotechnology and iShares MSCI Korea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI Korea and IShares Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Nasdaq Biotechnology are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI Korea has no effect on the direction of IShares Nasdaq i.e., IShares Nasdaq and IShares MSCI go up and down completely randomly.

Pair Corralation between IShares Nasdaq and IShares MSCI

Assuming the 90 days trading horizon iShares Nasdaq Biotechnology is expected to generate 0.77 times more return on investment than IShares MSCI. However, iShares Nasdaq Biotechnology is 1.3 times less risky than IShares MSCI. It trades about 0.02 of its potential returns per unit of risk. iShares MSCI Korea is currently generating about -0.04 per unit of risk. If you would invest  644.00  in iShares Nasdaq Biotechnology on August 27, 2024 and sell it today you would earn a total of  14.00  from holding iShares Nasdaq Biotechnology or generate 2.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iShares Nasdaq Biotechnology  vs.  iShares MSCI Korea

 Performance 
       Timeline  
iShares Nasdaq Biote 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, IShares Nasdaq is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
iShares MSCI Korea 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares MSCI Korea has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Etf's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the exchange-traded fund private investors.

IShares Nasdaq and IShares MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Nasdaq and IShares MSCI

The main advantage of trading using opposite IShares Nasdaq and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Nasdaq position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.
The idea behind iShares Nasdaq Biotechnology and iShares MSCI Korea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk